Navigation Links
ASTRO chairman to testify at CARE Act hearing
Date:6/8/2012

American Society for Radiation Oncology (ASTRO) Chairman Leonard Gunderson, MD, MS, FASTRO, will testify before the House Committee on Energy and Commerce Subcommittee on Health today on provisions of the Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (CARE Act) related to training and credentialing for medical imaging and radiation therapy technologists.

ASTRO strongly supports immediate passage of the CARE Act, which sets needed education and certification standards for radiation therapists, medical physicists and medical dosimetristscritical members of the team that delivers radiation therapy to cancer patients. Setting these minimum standards will help to ensure patients are treated accurately and safely and lead to fewer complications.

Today's hearing, "Examining the Appropriateness of Standards for Medical Imaging and Radiation Therapy Technologists," will examine the current state of training, identify any areas of deficiency and suggest ways of ensuring personnel have the appropriate background in the technical components of delivering treatments.

ASTRO has a long history of advocating to Congress on the need for improved safety in radiation therapy and creating minimum education and credentialing standards for treatment team members. This is also a core component of Target Safely, ASTRO's patient protection initiative, which was established in 2009 to ensure patients are receiving the safest treatments for their cancer.

Dr. Gunderson's testimony will inform Congress and the public that radiation therapy has been used for over 100 years as a safe and effective treatment for cancer with minimal side effects and that ASTRO is a leader in ensuring this continues. The testimony will outline several safety and patient quality initiatives the Society is working on to improve the quality of patient treatment and care, including:

  • Building on the bipartisan Patient Safety Act of 2005 by beginning work with a certified Patient Safety Organization to create the first national medical error reporting system for radiation oncology.
  • Assisting the Radiation Oncology Institute, ASTRO's foundation, in developing the National Radiation Oncology Registry, which will improve cancer patients' care by capturing real-time information on radiation treatment delivery and health outcomes.
  • Supporting physician participation in maintenance of certification activities and other continuing medical education programs to ensure all physicians are up-to-date on the latest treatment approaches.

These initiatives together with the CARE Act can prevent medical errors that can occur in a complex treatment such as radiation therapy.

Dr. Gunderson will testify that ASTRO wants patients to have peace of mind when it comes to safety, quality and efficacy of radiation therapy, and the CARE Act is a critical step toward that goal. ASTRO looks forward to working with Congress on additional policies that could be implemented to further enhance the quality of care patients receive.


'/>"/>

Contact: Nicole Napoli
nicolen@astro.org
703-839-7336
American Society for Radiation Oncology
Source:Eurekalert

Related medicine news :

1. Antibody therapy prevents gastrointestinal damage following radiation exposure in mice
2. Diagnostic Scans Tied to Radiation Risk for Gastro Patients
3. Gastro Woes Often Strike Rheumatoid Arthritis Patients
4. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
5. Football-related catastrophic brain injuries on the rise
6. Catastrophic Head Injuries to High School Football Players Rising
7. Gastroenterology special issue focuses on new directions of viral hepatitis care and research
8. Gastroenterology Societies issue sedation curriculum for gastrointestinal endoscopy
9. ASTRO wins 2012 Communicator Award
10. Grant awarded to help improve problem-solving skills for deaf and hard-of-hearing students
11. Cone beam CT proves better for visualizing some causes of hearing loss at half the radiation dose
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be ... conditions and has helped many women become pregnant upon treating their diagnosis. ... and simple outpatient evaluations. We can provide the necessary information to diagnose ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... domain expertise for sponsors and CROs to speed clinical development, has released ... software platform. Bioclinica AGILE RTSM provides seamless clinical supply forecasting ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now ... Invisalign® in Lutz, FL. With the help of this highly-effective, yet convenient ... fewer potential complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole ...
(Date:4/25/2017)... ... ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace – from medical ... heartened by the industry’s current surge. But another thing that unifies them is a ... last they can simply, safely and effectively end their aroma anguish thanks to a ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market is ... Low drug registration cost in Latin American countries and continuous ...
(Date:4/19/2017)... YORK , April 19, 2017 Cardiology devices ... the projected period The Cardiology Devices segment is ... than US$ 15 Mn in 2018 over 2017. By the ... a market valuation close to US$ 700 Mn, expanding at ... Devices segment dominated the Asia Pacific ...
(Date:4/19/2017)... MOUNTAIN VIEW, Calif. , April 19, 2017 /PRNewswire/ ... that it will release financial results for the first ... May 3, 2017.  The Company,s management team will host ... / 5:30 p.m. ET. Investors interested in ... dialing (844) 707-0665 for domestic callers or (703) 326-3030 ...
Breaking Medicine Technology: